Nexavar for Hepatocellular Carcinoma

If you have been diagnosed with a type of liver cancer called hepatocellular carcinoma, Nexavar® (sorafenib) may help slow down the progression of your disease. This prescription chemotherapy drug works to treat this specific type of cancer by reducing the activity of a certain type of protein in the body that the cancer cells need to grow and multiply. It is approved for use in adults age 18 and older, and is used when the cancer cannot be treated by surgery.
 
Clinical studies have shown that Nexavar can slow down the growth of liver cancer and extend survival in people with the disease. In a clinical study, people given Nexavar survived, on average, 10.7 months on treatment, compared with 7.9 months for people not given the drug.
 
(Click Nexavar Uses for a closer look at how Nexavar can help treat hepatocellular carcinoma in adults. This article also explains how this medication works, lists other possible uses, and talks about whether it is safe for use in children.)
7 Natural Ways to Reduce Your Cancer Pain
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.